Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Ibrunat 140mg Capsule:
Ibrunat 140mg Capsule is prescribed for the treatment of mantle-cell lymphoma and blood cancers such as chronic lymphocytic leukemia (CLL), particularly in patients who have received at least one prior treatment for CLL.
Mechanism of Ibrunat 140mg Capsule:
Ibrunat Capsule functions as a Bruton's tyrosine kinase inhibitor. By inhibiting the activity of abnormal proteins that signal cancer cells to proliferate, it effectively halts or slows down the spread of malignant cells.
Uses of Ibrunat 140mg Capsule:
Mantle-cell lymphoma
Chronic lymphocytic leukemia (CLL)
Side Effects of Ibrunat 140mg Capsule:
Ibrunat Capsule may cause certain side effects such as headaches, diarrhea, and nausea. It is important to note that it can also lead to a reduction in the number of platelets in the blood, thereby increasing susceptibility to infections. Regular blood tests may be required during treatment to monitor platelet counts and overall health.
Dosage and Duration of Treatment:
The dosage of Ibrunat Capsule should be taken as directed by the healthcare provider, and the duration of treatment may vary depending on individual response. It is essential to follow the prescribed regimen diligently to ensure optimal efficacy and minimize potential side effects.